Earnings Feed
Sign Up
Home/Filings/4/0001213900-19-005524
4//SEC Filing

Johnson Bankole A. 4

Accession 0001213900-19-005524

CIK 0001513525other
View on SEC.govCompany Profile

Filed

Mar 31, 8:00 PM ET

Accepted

Apr 1, 4:57 PM ET

Size

23.4 KB

Accession

0001213900-19-005524

Insider Transaction Report

Form 4
Period: 2019-03-28
ADIAL PHARMACEUTICALS, INC.ADIL
Johnson Bankole A.
Director10% Owner
Transactions
  • Purchase

    Common Stock

    2019-03-28$3.15/sh+40,000$125,808→ 314,768 total
  • Purchase

    Common Stock

    2019-03-29$3.30/sh+600$1,978→ 347,868 total
  • Purchase

    Common Stock

    2019-03-29$3.47/sh+30,000$104,154→ 344,768 total
  • Purchase

    Common Stock

    2019-03-29$3.47/sh+2,500$8,669→ 347,268 total
Holdings

  • Common Stock

    (indirect: By Trust)
    93,000

  • Common Stock

    (indirect: By Trust)
    22,320

  • Common Stock

    (indirect: By Trust)
    10,000

  • Common Stock

    (indirect: Aida Tiouririne)
    930

  • Stock Option

    Exercise: $5.70Exp: 2027-06-30→ Common Stock (5,580 underlying)
    5,580

  • Warrant to purchase common stock

    Exercise: $6.25From: 2018-07-31Exp: 2023-07-31→ Common Stock (189,714 underlying)
    189,714

  • Common Stock

    (indirect: By Trust)
    848,336

  • Common Stock

    (indirect: Ade Johnson)
    1,395

  • Common Stock

    (indirect: Lola Johnson)
    1,395

  • Common Stock

    (indirect: Lina Tiouririne)
    930

  • Common Stock

    (indirect: By LLC)
    40,463

  • Stock Option

    Exercise: $3.01Exp: 2029-03-23→ Common Stock (250,000 underlying)
    250,000

  • Common Stock

    (indirect: Efunbowale Johnson)
    4,650

  • Warrant to purchase common stock

    Exercise: $7.63From: 2017-10-10Exp: 2031-12-31→ Common Stock (3,275 underlying)
    3,275

  • Warrant to purchase common stock

    Exercise: $5.00From: 2018-11-12Exp: 2023-07-31→ Common Stock (17,600 underlying)
    17,600
Footnotes (5)
  • [F1]Medico-Trans Company, LLC is controlled by Bankole Johnson.
  • [F2]Dr. Johnson is the trustee of each of these trusts.
  • [F3]Dr. Johnson has a voting proxy on this person's behalf that entitles him to vote these shares.
  • [F4]Options to buy 3,100 shares are currently exercisable with the remaining options to buy 2,480 shares vesting 1/36th (155 shares) on the first day of each month over the remaining 16 months.
  • [F5]Options to buy 250,000 shares vest pro rata on a monthly basis over 36 months commencing March 24, 2019.

Documents

1 file

Issuer

ADIAL PHARMACEUTICALS, INC.

CIK 0001513525

→
Entity typeother

Related Parties

1
  • filerCIK 0001718158

Filing Metadata

Form type
4
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 4:57 PM ET
Size
23.4 KB
View on SEC.gov